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Nanomedicine: what’s in a definition?
Welcome to the second issue of the International Journal of Nanomedicine (IJN)! 
Nanomedicine research is certainly international, as we try to emphasize in each and 
every issue of IJN. Over the next several issues, this editorial section will take a closer 
look at various aspects of international nanomedicine research. What a better place 
to start than its definition. 
Although defining a term such as nanomedicine may sound simple, by comparing 
several main funding agencies from around the world, one quickly realizes that 
a uniform international definition of nanomedicine does not currently exist. This 
is typical of a new field, but can be problematic to those trying to understand the 
field, make significant contributions to it, and especially in how the public views 
nanomedicine. Clearly an established international gathering of nanomedicine experts 
would help establish an “internationally acceptable” definition and subsequent criteria 
for nanomedicine research.
For example, recently, the European Science Foundation (ESF 2004) took an 
extensive examination of the field of nanomedicine. The particular definition for 
nanomedicine that the Medical Standing Committee of the ESF compiled is “the science 
and technology of diagnosing, treating, and preventing disease and traumatic injury, of 
relieving pain, and of preserving and improving human health, using molecular tools 
and molecular knowledge of the human body” (ESF 2004). Further, they defined five 
main disciplines of nanomedicine: analytical tools; nanoimaging; nanomaterials and 
nanodevices; novel therapeutics and drug delivery systems; and clinical, regulatory, 
and toxicological issues. Compare and contrast these concepts with those presented 
on the United States’ National Institutes of Health Roadmap for Medical Research 
in Nanomedicine (NIH 2006), in which nanomedicine is defined as “an offshoot of 
nanotechnology, [which] refers to highly specific medical interventions at the molecular 
scale for curing disease or repairing damaged tissues, such as bone, muscle, or nerve”. 
Both reports emphasize that nanomedicine emerged from nanotechnology which is 
generally defined by the creation and use of materials at the level of molecules and 
atoms (sometimes specifically less than 100 nm, other times this dimension is more 
diffuse and confusing). The European report put it into simple terms where “the focus 
[of nanomedicine] is always on nanointeractions within a framework of a larger device 
or biologically with a sub-cellular (or cellular) system” (ESF 2004). This focus on 
elucidating nanoscale events may be one manner in which nanomedicine research 
separates itself from other medical research fields. But does it? 
Specifically speaking, similarities in the numerous definitions of nanomedicine 
from around the world center on molecular events and this is where people (including 
scientists and clinicians) get somewhat confused. For example, many researchers in 
the medical fields (such as biology, anatomy, pathology) often state when presented 
with definitions of nanomedicine: “I have been examining molecular interactions 
for decades inside and outside cells (such as cell membrane calcium fluxes, mRNA, 
protein synthesis) and now my research is called nanomedicine.” 
In comparison, similar statements were made by chemists and physicists (among 
others) over a decade ago when nanotechnology was first emphasized in various funding 
agencies. That is, statements such as “I have been studying atomic interactions for 
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decades, but why is my research now called nanotechnology?” 
were often asked. 
What separated nanotechnology from the study of 
fundamental atomic and molecular interactions that a 
traditional research field may accomplish (clearly, research 
that is still needed) was an emphasis on new properties 
of materials gained when controlling structures at the 
atomic and molecular level. It was this emphasis on the 
control of structures at the nanometer level leading to 
significantly changed properties that allowed (and still 
allows) nanotechnology to be separated from other traditional 
science fields. 
But what about the subset of nanotechnology, nano­
medicine? How does nanomedicine separate itself from other 
traditional medical research fields? Is it really different from 
research that scientists conducted a decade or more ago? 
And, a possibly more important question, does it matter to 
the future of nanomedicine if it does not separate itself from 
these other traditional medical research fields? All questions 
worth asking for this maturing field.
IJN takes a firm stance in this respect and emphasizes 
nanomedicine research in which significantly changed 
medical events are elucidated only by concentrating on 
nanoscale events. In this respect, our attempt to separate 
nanomedicine from other traditional medical research fields 
is a focus on significantly changed medically related events 
that result by concentrating solely on the nanoscale. I ask 
you to join me in this, our second issue, to discover medical 
advances made in this exciting nanomedicine research field!
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